TP53-mut and NSMP were associated with poor prognosis in high-grade endometrial carcinoma, whereas the glandular/luminal phenotype was associated with better outcomes than the EMT-like phenotype, an effect largely influenced by carcinosarcoma prevalence. Here, TP53 is linked to endometrial carcinoma.